Although further studies are needed, preliminary findings suggest the possible clinical efficacy of heparin in improving post-traumatic stress disorders (PTSD) symptoms, and potentially averting subsequent thrombotic sequalae. Regardless of the mechanistic relationship between heparin and the pathogenesis of PTSD, there are some plausible biological mechanisms and promising therapeutic implications that would warrant the design of clinical trials to investigate the potential benefits of heparin in (human) patients with PTSD.

Heparin and Posttraumatic Stress Disorder

Lippi, Giuseppe;
2025-01-01

Abstract

Although further studies are needed, preliminary findings suggest the possible clinical efficacy of heparin in improving post-traumatic stress disorders (PTSD) symptoms, and potentially averting subsequent thrombotic sequalae. Regardless of the mechanistic relationship between heparin and the pathogenesis of PTSD, there are some plausible biological mechanisms and promising therapeutic implications that would warrant the design of clinical trials to investigate the potential benefits of heparin in (human) patients with PTSD.
2025
Inglese
STAMPA
Esperti anonimi
51
4
471
473
3
heparin; post-traumatic stress disorders, COVID-19
https://www.thieme-connect.de/products/ejournals/abstract/10.1055/s-0044-1788697
none
info:eu-repo/semantics/article
Lippi, Giuseppe; Favaloro, Emmanuel J
2
01 Contributo in rivista::01.01 Articolo in Rivista
262
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11562/1132346
Citazioni
  • ???jsp.display-item.citation.pmc??? 1
  • Scopus 1
  • ???jsp.display-item.citation.isi??? 0
social impact